These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Su WP; Perniciaro C; Rogers RS; White JW Cutis; 1994 Dec; 54(6):395-9. PubMed ID: 7867381 [TBL] [Abstract][Full Text] [Related]
8. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndrome. Tüngler V; Silver RM; Walkenhorst H; Günther C; Lee-Kirsch MA Br J Dermatol; 2012 Jul; 167(1):212-4. PubMed ID: 22356656 [No Abstract] [Full Text] [Related]
9. [Evaluation of the past history of chilblain in cases of systemic lupus erythematosus (SLE) and its similar diseases]. Morioka N; Tsuchida T; Ueda Y; Ishibashi Y Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):615-22. PubMed ID: 1920892 [TBL] [Abstract][Full Text] [Related]
10. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1). Günther C; Berndt N; Wolf C; Lee-Kirsch MA JAMA Dermatol; 2015 Apr; 151(4):426-31. PubMed ID: 25517357 [TBL] [Abstract][Full Text] [Related]
11. Docetaxel-induced relapse of subacute cutaneous lupus erythematosus and chilblain lupus. Lebeau S; També S; Sallam MA; Alhowaish A; Tschanz C; Masouyé I; Borradori L J Dtsch Dermatol Ges; 2013 Sep; 11(9):871-4. PubMed ID: 23848065 [No Abstract] [Full Text] [Related]
12. Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies-Taming T REX. Damsky W; King BA JAMA Dermatol; 2019 Mar; 155(3):283-284. PubMed ID: 30673073 [No Abstract] [Full Text] [Related]
14. Lupus pernio or chilblain lupus?: two different entities. Arias-Santiago SA; Girón-Prieto MS; Callejas-Rubio JL; Fernández-Pugnaire MA; Ortego-Centeno N Chest; 2009 Sep; 136(3):946-947. PubMed ID: 19736207 [No Abstract] [Full Text] [Related]
15. Chilblain lupus erythematosus in a patient affected by Hodgkin lymphoma. Passarini B; Pileri A; Neri I; Piraccini BM; Reggiani C; Patrizi A Australas J Dermatol; 2013 Feb; 54(1):74-5. PubMed ID: 23373885 [No Abstract] [Full Text] [Related]
16. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis. Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362 [TBL] [Abstract][Full Text] [Related]
17. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Franceschini F; Calzavara-Pinton P; Quinzanini M; Cavazzana I; Bettoni L; Zane C; Facchetti F; Airò P; McCauliffe DP; Cattaneo R Lupus; 1999; 8(3):215-9. PubMed ID: 10342714 [TBL] [Abstract][Full Text] [Related]
18. Chilblain lupus erythematosus treated successfully with mycophenolate mofetil. Gouillon L; Debarbieux S; Berruyer M; Fabien N; Lega JC; Thomas L Int J Dermatol; 2017 Aug; 56(8):e158-e159. PubMed ID: 28345755 [No Abstract] [Full Text] [Related]
19. [Chilblain lupus erythematosus. A case report]. Brado B; Keilholz U; Tilgen W; Pezzutto A; Gissler M; Hunstein W Internist (Berl); 1992 Oct; 33(10):701-3. PubMed ID: 1428687 [No Abstract] [Full Text] [Related]
20. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus. Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693 [No Abstract] [Full Text] [Related] [Next] [New Search]